DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Mycostatin (Nystatin Topical) - Published Studies

 
 



Mycostatin Related Published Studies

Well-designed clinical trials related to Mycostatin (Nystatin Topical)

Comparison of therapeutic effect of aqueous extract of garlic and nystatin mouthwash in denture stomatitis. [2012]

Randomised controlled trial of prophylactic fluconazole versus nystatin for the prevention of fungal colonisation and invasive fungal infection in very low birth weight infants. [2011.05]

Oral sustained release nystatin tablets for the treatment of oral candidiasis: formulation development and validation of UV spectrophotometric analytical methodology for content determination. [2010.05]

Comparison of fluconazole and nystatin oral suspensions for prophylaxis of systemic fungal infection in very low birthweight infants. [2010.01]

Effects of nystatin, fluconazole and propolis on poly(methyl methacrylate) resin surface. [2008]

Prevention of fungal peritonitis with nystatin prophylaxis in patients receiving CAPD. [2007.09]

Oral nystatin prophylaxis to prevent invasive candidiasis in Neonatal Intensive Care Unit. [2006.11]

Oral nystatin prophylaxis of Candida spp. colonization in ventilated critically ill patients. [2005.11]

Effect of a buccal bioadhesive nystatin tablet on the lifetime of a Provox silicone tracheoesophageal voice prosthesis. [2005.03]

Well-designed clinical trials possibly related to Mycostatin (Nystatin Topical)

Efficacy and safety of two different antifungal pastes in infants with diaper dermatitis: a randomized, controlled study. [2010.09]

A randomised controlled trial comparing Triadcortyl with 10% glycerine-ichthammol in the initial treatment of severe acute otitis externa. [2008.08]

In vitro and in vivo activity of Melaleuca alternifolia mixed with tissue conditioner on Candida albicans. [2008.03]

Efficacy of enteral decontamination in the prevention of anastomotic dehiscence and pulmonary infection in esophagogastric surgery. [2008]

Elevation of Candida IgG antibodies in patients with medically unexplained symptoms. [2007.12]

The use of topical nonabsorbable gastrointestinal antifungal prophylaxis to prevent fungal infections in critically ill immunocompetent patients: a meta-analysis. [2005.10]

Why do different criteria for 'cure' yield different conclusions in comparing two treatments for bacterial vaginosis? [2005.09]

Other research related to Mycostatin (Nystatin Topical)

[The clinical research of nystatin in prevention of invasive fungal infections in patients on mechanical ventilation in intensive care unit]. [Article in Chinese] [2013]

Prospective trial finds nystatin mouthwash effective prophylaxis for pulmonary invasive fungal infections that originate in the throat of patients with hematologic malignancies. [2013]

Is ototopical nystatin ototoxic? A chinchilla model. [2011.12]

Comparison of therapeutic effect of aqueous extract of garlic and nystatin mouthwash in denture stomatitis. [2011.11.30]

Cutaneous hyalohyphomycosis caused by Paecilomyces lilacinus successfully treated by oral voriconazole and nystatin packing. [2011.08]

Randomised controlled trial of prophylactic fluconazole versus nystatin for the prevention of fungal colonisation and invasive fungal infection in very low birth weight infants. [2011]

Enhancement of dissolution of nystatin from buccoadhesive tablets containing various surfactants and a solid dispersion formulation. [2010.11]

Randomised controlled trial of prophylactic fluconazole versus nystatin for the prevention of fungal colonisation and invasive fungal infection in very low birth weight infants. [2010.07.21]

Use of xanthan and its binary blends with synthetic polymers to design controlled release formulations of buccoadhesive nystatin tablets. [2010.07]

Targeted antifungal delivery system: beta-glucosidase sensitive nystatin-star poly(ethylene glycol) conjugate. [2010.02.15]

Synthesis and study of the antifungal activity of new mono- and disubstituted derivatives of a genetically engineered polyene antibiotic 28,29-didehydronystatin A1 (S44HP). [2010.02]

Comparison of fluconazole and nystatin oral suspensions for prophylaxis of systemic fungal infection in very low birthweight infants. [2010]

Oral nystatin prophylaxis and neonatal fungal infections. [2009.11]

Prophylactic oral nystatin for preterm babies under 33 weeks' gestation decreases fungal colonisation and invasive fungaemia. [2009.07]

Comparison of Fluconazole and Nystatin Oral Suspensions for Prophylaxis of Systemic Fungal Infection in Very Low Birthweight Infants. [2009.06.05]

Development and in vitro evaluation of a mucoadhesive vaginal delivery system for nystatin. [2009.02]

Fungal prophylaxis in very low birth weight neonates: nystatin, fluconazole or nothing? [2008.06]

HPLC method for the determination of nystatin in saliva for application in clinical studies. [2007.11.05]

Quantitative determination of nystatin in human plasma using LC-MS after inhalative administration in healthy subjects. [2006.11.21]

Stability of amphotericin B and nystatin in antifungal mouthrinses containing sodium hydrogen carbonate. [2006.09.26]

Effect of the association of nystatin with a tissue conditioner on its ultimate tensile strength. [2006.09]

Safety, efficacy and pharmacokinetics of tuftsin-loaded nystatin liposomes in murine model. [2006.05]

Enhanced efficacy of pH-sensitive nystatin liposomes against Cryptococcus neoformans in murine model. [2006.02]

["Mixed" and "miscellaneous" vulvovaginitis: diagnostics and therapy of vaginal administration of nystatin and nifuratel] [2005.05]

Potential ototoxicity from triamcinolone, neomycin, gramicidin and nystatin (Tri-Adcortyl) cream. [2005.01]

Other possibly related research studies

Topical voriconazole solution for cutaneous aspergillosis in a pediatric patient after bone marrow transplant. [2006.08]

Great toenail onychomycosis caused by Syncephalastrum racemosum. [2006.01.27]

Survey of topical oral solutions for the treatment of chemo-induced oral mucositis. [2005.12]

Effects of beta-thujaplicin on anti-Malassezia pachydermatis remedy for canine otitis externa. [2005.12]

In vitro susceptibility of oral Candida to seven antifungal agents. [2005.12]

Prednisone-free maintenance immunosuppression-a 5-year experience. [2005.10]

Pharmacological assay of Cordia verbenacea V: oral and topical anti-inflammatory activity, analgesic effect and fetus toxicity of a crude leaf extract. [2005.05]

Safety and success of kidney transplantation and concomitant immunosuppression in HIV-positive patients. [2005.04]

Liposomal polyene antibiotics. [2005]

Study of anticandidal activity of carvacrol and eugenol in vitro and in vivo. [2005.04]

[Use of topical antifungal agents] [2006.05]

Candida-related denture stomatitis: a pilot study of the efficacy of an amorolfine antifungal varnish. [2005.01]

Otomycosis: clinical and mycological study of 97 cases. [2006]

Design of novel antifungal mucoadhesive films Part I. Pre-formulation studies. [2007.02.07]

Observational study of bone-anchored hearing aid infection rates using different post-operative dressings. [2006.10]

Myringoplasty: a comparison of bismuth iodoform paraffin paste gauze pack and tri-adcortyl ointment ear dressing. [2007.04]

Trimethoprim-sulfamethoxazole induced rash and fatal hematologic disorders. [2006.02]

High-dose methylprednisolone influences the physiology and virulence of Candida albicans ambiguously and enhances the candidacidal activity of the polyene antibiotic amphotericin B and the superoxide-generating agent menadione. [2007.03]

Design of novel antifungal mucoadhesive films. Part II. Formulation and in vitro biopharmaceutical evaluation. [2007.05.24]

Effects of solubilizing surfactants and loading of antiviral, antimicrobial, and antifungal drugs on their release rates from ethylene vinyl acetate copolymer. [2007.08]

Oral manifestation of chronic mucocutaneous candidiasis: seven case reports. [2007.10]

[Treatment of fungal infections of upper respiratory tract and ear] [2007]

In vitro susceptibility patterns of fungi associated with keratomycosis in horses of the northeastern United States: 68 cases (1987-2006). [2007.10.01]

Posaconazole for the management of mucosal candidiasis. [2007.06]

An ex-vivo oral mucosa infection model for the evaluation of the topical activity of antifungal agents. [2008.01]

Antifungal prophylaxis for the prevention of neonatal candidiasis? [2008.04]

Cholesterol suppresses cellular TGF-beta responsiveness: implications in atherogenesis. [2007.10.15]

Anti-inflammatory and analgesic activities of the ethanolic extracts from Zanthoxylum riedelianum (Rutaceae) leaves and stem bark. [2007.08]

Denture stomatitis. [2007.03]

Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of bis[micro2-(benzimidazol-2-yl)-2-ethanethiolato-N,S,S-chloro-palladium(II)] dimer, [(micro2-CH2CH2NHNCC6H4)PdCl]2.C2H5OH complex. [2007.08]

Ototopical antifungals and otomycosis: a review. [2008.04]

Oral manifestation of cytomegalovirus associated with herpes simplex virus in renal transplant recipient. [2008.06]

Experience with Alemtuzumab (Campath-1H) as induction agent in renal transplantation followed by steroid-free immunosuppression. [2008.04]

Fulminant septicemia of Bacillus cereus resistant to carbapenem in a patient with biphenotypic acute leukemia. [2008.10]

Local treatment of vulvovaginal candidosis : general and practical considerations. [2008]

Evaluation and treatment of oral candidiasis in HIV/AIDS patients in Enugu, Nigeria. [2008.07]

A selective T-type Ca2+ channel blocker R(-) efonidipine. [2008.06]

Prophylactic oral/topical non-absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants. [2009.10.07]

Cutaneous fungal infections in the United States: Analysis of the National Ambulatory Medical Care Survey (NAMCS) and National Hospital Ambulatory Medical Care Survey (NHAMCS), 1995-2004. [2009.07]

Superficial distribution and identification of antifungal/antimicrobial agents on a modified tissue conditioner by SEM-EDS microanalysis: a preliminary study. [2009.10]

Harnessing competing endocytic pathways for overcoming the tumor-blood barrier: magnetic resonance imaging and near-infrared imaging of bifunctional contrast media. [2009.07.01]

[Evaluation of susceptibility to antifungal agents of fungal strains isolated from pregnant women with diabetes and healthy pregnant women] [2009.04]

Anti-inflammatory activity of aqueous and alkaline extracts from mushrooms (Agaricus blazei Murill). [2009.04]

Inhibition of Candida albicans biofilm formation on denture material. [2009.05]

Alterations in growth and branching of Neurospora crassa caused by sub-inhibitory concentrations of antifungal agents. [2009.01]

Support for the role of Candida spp. in extensive caries lesions of children. [2009.01]

[A cat with diarrhoea associated with the massive presence of Cyniclomyces guttulatus in the faeces] [2009.03.01]

[Mixed vaginitis prevalence in Latin-American women, according to physician perception. Preference, effectiveness and security of clindamycin plus ketoconazole] [2008.11]

Are topical antimicrobials effective against bacteria that are highly resistant to systemic antibiotics? [2009.01]

Novel mucoadhesive extended release tablets for treatment of oral candidosis: "in vivo" evaluation of the biopharmaceutical performance. [2009.05]

Effect of an antifungal denture liner on the saliva yeast count in patients with denture stomatitis: a pilot study. [2008.09]

Sodium iodide associated to salicylic acid in the topical management of chronic oral candidiasis: a randomized trial. [2010.07]

Fluconazole to prevent systemic fungal infections in infants: reviewing the evidence. [2010.09]

Strategies to prevent invasive candidal infection in extremely preterm infants. [2010.09]

[Local combined therapy of vaginal infections by nifuratel-nistatin] [2010.02]

Current concepts in systemic and topical therapy for superficial mycoses. [2010.03.04]

Candidosis, a new challenge. [2010.03.04]

[Oral candidiasis and dentures] [2010.04]

Prevalence and management of non-albicans vaginal candidiasis. [2010.04]

Oral mucous squamous cell carcinoma-an anticipated consequence of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED). [2010.05]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017